OssDsign AB
SE0012570448 Short position disclosed on June 1, 2026.
0.81% of the capital sold short
1 disclosing funds
7 disclosures on record
Funds holding OssDsign AB Titelia
Evolution of the disclosed total
0%0.25%0.5%0.75%1%
Mar 2026May 2026Jul 2026
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| GSA Capital Partners LLP | 0.81% | new | June 1, 2026 |
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| June 1, 2026 | GSA Capital Partners LLP | 0.81% | still open |
| April 23, 2026 | GSA Capital Partners LLP | 0.70% | still open |
| April 20, 2026 | GSA Capital Partners LLP | 0.69% | still open |
| April 14, 2026 | GSA Capital Partners LLP | 0.70% | still open |
| March 3, 2026 | GSA Capital Partners LLP | 0.60% | still open |
| February 16, 2026 | GSA Capital Partners LLP | 0.50% | still open |
| February 4, 2026 | Citadel Securities (Europe) Limited | 0.53% | still open |
Other companies sold short in Sweden
- Samhällsbyggnadsbolaget i Norden AB 12.30% of the capital sold short
- Elekta AB (publ) 10.32% of the capital sold short
- JM AB 7.01% of the capital sold short
- Embracer Group AB 5.83% of the capital sold short
- Hemnet Group AB (publ) 5.59% of the capital sold short
- Truecaller AB 5.43% of the capital sold short
- Bonesupport Holding AB 5.38% of the capital sold short
- Xvivo Perfusion Aktiebolag 5.02% of the capital sold short
- Tobii AB 4.34% of the capital sold short
- Stillfront Group AB (publ) 3.87% of the capital sold short
- Svenska Cellulosa Aktiebolaget SCA 3.77% of the capital sold short
- RaySearch Laboratories AB (publ) 3.63% of the capital sold short